FDA Warns of Joint Pain Tied to Common Type 2 Diabetes Drugs

FRIDAY, Aug. 28, 2015 (HealthDay News) -- Use of a class of widely prescribed medications for type 2 diabetes is tied to severe joint pain in some patients, the U.S. Food and Drug Administration warned on Friday.

As Tropical Storm Erika Eyes Southeastern U.S., Residents Need to Prepare

FRIDAY, Aug. 28, 2015 (HealthDay News) -- With tropical storm Erika motoring toward the southeastern United States, hurricane season is clearly under way and people who live in the paths of these dangerous storms need to be prepared.

Many Seniors With Cancer Use Alternative Medicines: Study

FRIDAY, Aug. 28, 2015 (HealthDay News) -- Many elderly cancer patients use alternative medicines, including some that could interfere with their treatment, a new study shows.

Guidelines for Preventing Catheter Infections in ICU Often Ignored: Study

FRIDAY, Aug. 28, 2015 (HealthDay News) -- Many health-care providers don't follow guidelines meant to reduce the risk of infection from catheters placed in the arteries of intensive care unit patients, a new study finds.

FDA Approves Repatha for High Cholesterol

FRIDAY, Aug. 28, 2015 (HealthDay News) -- Repatha (evolocumab) has been approved by the U.S. Food and Drug Administration, the second non-statin drug in its class approved to treat high cholesterol.

Health Highlights: Aug 28, 2015

Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:

Many Parents Unaware of Dangers E-Cigarettes Pose to Little Kids: Survey

FRIDAY, Aug. 28, 2015 (HealthDay News) -- Many parents don't understand that the liquid nicotine used in electronic cigarettes poses a serious danger to young children, a new survey indicates.

Obesity May Be Linked to Greater Risk of Stillbirth

FRIDAY, Aug. 28, 2015 (HealthDay News) -- Obese pregnant women may have a nearly twofold increased risk of stillbirth, a new study says.

Health Tip: Dive Safely

(HealthDay News) -- Reckless diving can lead to serious injury, including permanent paralysis.

FDA Approves Second Drug in New Class of Cholesterol-Lowering Medications

THURSDAY, Aug. 27, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Thursday approved a second drug that's part of a potent new class of medications that sharply cut levels of "bad" LDL cholesterol.